Wahab; Atia-tul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wahab; Atia-tul.The latest application filed is for "bio-catalyzed synthesis of potent anti-inflammatory agents from medroxyprogesterone acetate".

Company Profile

4.12.34

Wahab; Atia-tul - Karachi PK
Wahab; Atia-tul- - Karachi PK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bio-catalyzed Synthesis of Potent Anti-inflammatory Agents from Medroxyprogesterone Acetate App 20220145335 - Choudhary; Muhammad Iqbal ; et al.	2022-05-12
Bio-catalyzed Synthesis of New Aromatase Inhibitors through Structural Modifications of Anticancer Drug Formestane App 20210380630 - Wahab; Atia-tul- ; et al.	2021-12-09
Synthesis of Anti-inflammatory and Anti-cancer Agents through Fungal Transformation of Mibolerone App 20210369740 - Choudhary; Muhammad Iqbal ; et al.	2021-12-02
Derivatives of 4-aminoantipyrine as anti-Alzheimers butyrylcholinesterase inhibitors App 20210363108 - Siddiqui; Hina ; et al.	2021-11-25
Prevention and Treatment of SARS-CoV-2 Infection by Mentha piperita and Flos chrysanthemi Extracts alone, and their Combination App 20210361733 - Rahman; Atta-ur- ; et al.	2021-11-25
Dietary herbal health supplement for the management and treatment of Parkinson's disease App 20210330726 - Choudhary; Muhammad Iqbal ; et al.	2021-10-28
Synthesis of New Potent Aromatase Inhibitors Through Biocatalysis of Anti-Cancer Drugs, Atamestane, Drostanolone Enanthate, and Exemestane App 20210308144 - Wahab; Atia-tul- ; et al.	2021-10-07
Potent aromatase inhibitors through fungal transformation of anti-cancer drug testolactone: An approach towards treatment of breast cancer App 20210230214 - Choudhary; Muhammad Iqbal ; et al.	2021-07-29
Food Supplement To Alleviate Symptoms Of Parkinson's Disease App 20200397846 - Choudhary; Muhammad Iqbal ; et al.	2020-12-24
Food supplement to alleviate symptoms of Parkinson's disease Grant 10,849,953 - Choudhary , et al. December 1, 2	2020-12-01
4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one (Ropinirole) a New Inhibitor of Jack bean Urease Enzyme: An Example of Drug Repurposing App 20170252323 - Khan; Jalaluddin Azam Jalal ; et al.	2017-09-07
4-hydroxybenzohydarzide-a New Class Of Angiogenic Enzyme Thymidine Phosphorylase Inhibitors App 20170246130 - Choudhary; Muhammad Iqbal ; et al.	2017-08-31
Drug repositioning: urease inhibitory activity of (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (captopril) Grant 9,688,628 - Khan , et al. June 27, 2	2017-06-27
Potent Inhibitors Of Human Carbonic Anhydrase Ii And Bovine Carbonic Anhydrase Ii And Their Mechanism Of Action App 20170073306 - Choudhary; Muhammad Iqbal ; et al.	2017-03-16
Schiff bases of thiazoles: a new class of ureases inhibitors Grant 9,447,057 - Choudhary , et al. September 20, 2	2016-09-20
Thiourea derivatives Grant 9,387,186 - Choudhary , et al. July 12, 2	2016-07-12
Schiff Bases Of Thiazoles: A New Class Of Ureases Inhibitors App 20150368214 - Choudhary; Muhammad Iqbal ; et al.	2015-12-24
Thiourea Derivatives App 20150335594 - Choudhary; Muhammad Iqbal ; et al.	2015-11-26
Treatment and inhibition of protozoal diseases with nandrolone and its derivatives Grant 9,173,888 - Baydoun , et al. November 3, 2	2015-11-03
THIOUREA DERIVATIVES AS a-CHYMOTRYPSIN INHIBITORS App 20150080580 - Rahman; Atta-ur ; et al.	2015-03-19
Anti-glycation Properties Of Oxindole Derivatives App 20150038543 - Choudhary; Muhammad Iqbal ; et al.	2015-02-05
Artonin I to treat resistant infectious Staphylococcus aureus Grant 8,889,733 - Choudhary , et al. November 18, 2	2014-11-18
Heterocyclic Schiff's Bases As Novel And New Antiglycation Agents App 20140221429 - Al-Resayes; Saud Ibrahim ; et al.	2014-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.